Open access
Sep 2026
Benzyl isothiocyanate alleviates neural damage in experimental autoimmune uveitis by modulating the TREM-1/PI3K/AKT signaling pathway
Purpose: To investigate whether Benzyl isothiocyanate (BITC) can improve experimental autoimmune uveitis (EAU) and explore its potential mechanism. Methods: To evaluate the therapeutic efficacy of BITC, EAU was induced in C57BL/6 mice via immunization with IRBP 651-670 . Clinical scores and histopathological s...
Si-Jie Liu, Wen-Dan Yi, Yi-Qing Ji et al.
· Frontiers in Pharmacology · 0 citations